The cellular and molecular components involved in pre-metastatic niche formation in colorectal cancer liver metastasis

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Jones RP, Kokudo N, Folprecht G, et al. Colorectal liver metastases: a critical review of state of the art. Liver Cancer. 2016 Nov;6(1):66–71.
   PubMed Web of Science ®Google Scholar
• Seyfried TN, Huysentruyt LC. On the origin of cancer metastasis. Crit Rev Oncog. 2013;18(1–2):43–73.
   PubMedGoogle Scholar
• Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989 Aug;8(2):98–101.
   PubMed Web of Science ®Google Scholar
• Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005 Dec 8;438(7069):820–827.
   PubMed Web of Science ®Google Scholar
• Doglioni G, Parik S, Fendt SM. Interactions in the (Pre)metastatic niche support metastasis formation. Front Oncol. 2019;9:219–225.
   PubMed Web of Science ®Google Scholar
• Liu Y, Cao X. Characteristics and significance of the pre-metastatic niche. Cancer Cell. 2016 Nov 14; 30(5):668–681.
   PubMed Web of Science ®Google Scholar
• Aguado BA, Bushnell GG, Rao SS, et al. Engineering the pre-metastatic niche. Nat Biomed Eng. 2017;1(6):1–28.
   Web of Science ®Google Scholar
• Eveno C, Hainaud P, Rampanou A, et al. Proof of prometastatic niche induction by hepatic stellate cells. J Surg Res. 2015 Apr;194(2):496–504.
   PubMed Web of Science ®Google Scholar
• Shao Y, Chen T, Zheng X, et al. Colorectal cancer-derived small extracellular vesicles establish an inflammatory premetastatic niche in liver metastasis. Carcinogenesis. 2018 Dec 13;39(11):1368–1379.
   PubMed Web of Science ®Google Scholar
• Wang D, Sun H, Wei J, et al. CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer. Cancer Res. 2017;77(13):3655–3665.
   PubMed Web of Science ®Google Scholar
• Zeng Z, Li Y, Pan Y, et al. Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat Commun. 2018 Dec 19;9(1):5395–5408.
   PubMed Web of Science ®Google Scholar
• Ji Q, Zhou L, Sui H, et al. Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation. Nat Commun. 2020 Mar 5;11(1):1211–1228.
   PubMed Web of Science ®Google Scholar
• Kaplan RN, Psaila B, Lyden D. Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond. Cancer Metastasis Rev. 2006 Dec;25(4):521–529.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ding Y, Guo N, et al. MDSCs: key criminals of tumor pre-metastatic niche formation. Front Immunol. 2019;10:172–187.
   PubMed Web of Science ®Google Scholar
• Kitamura T, Fujishita T, Loetscher P, et al. Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model. Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13063–13068.
   PubMed Web of Science ®Google Scholar
• Zhao L, Lim SY, Gordon-Weeks AN, et al. Recruitment of a myeloid cell subset (CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis. Hepatology. 2013 Feb;57(2):829–839.
   PubMed Web of Science ®Google Scholar
• Itatani Y, Kawada K, Fujishita T, et al. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis. Gastroenterology. 2013 Nov;145(5):1064–1075.
   PubMed Web of Science ®Google Scholar
• Inamoto S, Itatani Y, Yamamoto T, et al. Loss of SMAD4 promotes colorectal cancer progression by accumulation of myeloid-derived suppressor cells through the CCL15-CCR1 chemokine axis. Clin Cancer Res off J Am Assoc Cancer Res. 2016 Jan 15;22(2):492–501.
   PubMed Web of Science ®Google Scholar
• Lim SY, Gordon-Weeks A, Allen D, et al. Cd11b(+) myeloid cells support hepatic metastasis through down-regulation of angiopoietin-like 7 in cancer cells. Hepatology. 2015 Aug;62(2):521–533.
   PubMed Web of Science ®Google Scholar
• Lin Q, Ren L, Jian M, et al. The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1-STAT3 signaling pathway. Cell Death Dis. 2019 Sep 18;10(10):693–711.
   PubMedGoogle Scholar
• Sinha P, Okoro C, Foell D, et al. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol. 2008 Oct 1;181(7):4666–4675.
   PubMed Web of Science ®Google Scholar
• Jablonska J, Lang S, Sionov RV, et al. The regulation of pre-metastatic niche formation by neutrophils. Oncotarget. 2017 Dec 19;8(67):112132–112144.
   PubMedGoogle Scholar
• Mizuno R, Kawada K, Itatani Y, et al. The role of tumor-associated neutrophils in colorectal cancer. Int J Mol Sci. 2019 Jan 27;20(3):529–542.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Kikuchi H, Ohta M, et al. TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche. Cancer Res. 2008 Dec 1;68(23):9754–9762.
   PubMed Web of Science ®Google Scholar
• Hirai H, Fujishita T, Kurimoto K, et al. CCR1-mediated accumulation of myeloid cells in the liver microenvironment promoting mouse colon cancer metastasis. Clin Exp Metastasis. 2014 Dec;31(8):977–989.
   PubMed Web of Science ®Google Scholar
• Seubert B, Grünwald B, Kobuch J, et al. Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice. Hepatology. 2015 Jan;61(1):238–248.
   PubMed Web of Science ®Google Scholar
• Ogawa R, Yamamoto T, Hirai H, et al. Loss of SMAD4 promotes colorectal cancer progression by recruiting tumor-associated neutrophils via the CXCL1/8-CXCR2 Axis. Clin Cancer Res off J Am Assoc Cancer Res. 2019 May 1;25(9):2887–2899.
   PubMed Web of Science ®Google Scholar
• Ruffell B, Affara NI, Coussens LM. Differential macrophage programming in the tumor microenvironment. Trends Immunol. 2012 Mar;33(3):119–126.
   PubMed Web of Science ®Google Scholar
• Lin Y, Xu J, Lan H. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol. 2019 Jul 12;12(1):76–91.
   PubMedGoogle Scholar
• Takano Y, Masuda T, Iinuma H, et al. Circulating exosomal microRNA-203 is associated with metastasis possibly via inducing tumor-associated macrophages in colorectal cancer. Oncotarget. 2017 Oct 3;8(45):78598–78613.
   PubMedGoogle Scholar
• Grossman JG, Nywening TM, Belt BA, et al. Recruitment of CCR2(+) tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancer. Oncoimmunology. 2018;7(9):1–11.
   Web of Science ®Google Scholar
• Sleeman JP. The metastatic niche and stromal progression. Cancer Metastasis Rev. 2012 Dec;31(3–4):429–440.
   PubMed Web of Science ®Google Scholar
• Lu P, Weaver VM, Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol. 2012 Feb 20;196(4):395–406.
   PubMed Web of Science ®Google Scholar
• Eble JA, Niland S. The extracellular matrix in tumor progression and metastasis. Clin Exp Metastasis. 2019 Jun;36(3):171–198.
   PubMed Web of Science ®Google Scholar
• Brodt P. Role of the microenvironment in liver metastasis: from pre- to prometastatic niches. Clin Cancer Res off J Am Assoc Cancer Res. 2016 Dec 15;22(24):5971–5982.
   PubMed Web of Science ®Google Scholar
• Gandhi CR. Hepatic stellate cell activation and pro-fibrogenic signals. J Hepatol. 2017 Nov;67(5):1104–1105.
   PubMed Web of Science ®Google Scholar
• Kang N, Gores GJ, Shah VH. Hepatic stellate cells: partners in crime for liver metastases? Hepatology. 2011 Aug;54(2):707–713.
   PubMed Web of Science ®Google Scholar
• Bandapalli OR, Macher-Goeppinger S, Schirmacher P, et al. Paracrine signalling in colorectal liver metastases involving tumor cell-derived PDGF-C and hepatic stellate cell-derived PAK-2. Clin Exp Metastasis. 2012 Jun;29(5):409–417.
   PubMed Web of Science ®Google Scholar
• Benedicto A, Romayor I, Arteta B. CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver. Oncol Rep. 2018 Apr;39(4):2022–2030.
   PubMed Web of Science ®Google Scholar
• Wang Y, Tu K, Liu D, et al. p300 acetyltransferase is a cytoplasm-to-nucleus shuttle for SMAD2/3 and TAZ nuclear transport in transforming growth factor β-stimulated hepatic stellate cells. Hepatology. 2019 Oct;70(4):1409–1423.
   PubMed Web of Science ®Google Scholar
• Tan HX, Gong WZ, Zhou K, et al. CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer. Cancer Biol Ther. 2020;21(3):258–268.
   PubMed Web of Science ®Google Scholar
• Shimizu S, Yamada N, Sawada T, et al. In vivo and in vitro interactions between human colon carcinoma cells and hepatic stellate cells. Jpn J Cancer Res. 2000 Dec;91(12):1285–1295.
   PubMedGoogle Scholar
• Matsusue R, Kubo H, Hisamori S, et al. Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis. Ann Surg Oncol. 2009 Sep;16(9):2645–2653.
   PubMed Web of Science ®Google Scholar
• Mazzocca A, Coppari R, De Franco R, et al. A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res. 2005 Jun 1;65(11):4728–4738.
   PubMed Web of Science ®Google Scholar
• Huang WH, Zhou MW, Zhu YF, et al. The role of hepatic stellate cells in promoting liver metastasis of colorectal carcinoma. Onco Targets Ther. 2019;12:7573–7580.
   PubMed Web of Science ®Google Scholar
• Yeung OW, Lo CM, Ling CC, et al. Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma. J Hepatol. 2015 Mar;62(3):607–616.
   PubMed Web of Science ®Google Scholar
• Doak GR, Schwertfeger KL, Wood DK. Distant relations: macrophage functions in the metastatic niche. Trends Cancer. 2018 Jun;4(6):445–459.
   PubMed Web of Science ®Google Scholar
• Keirsse J, Van Damme H, Geeraerts X, et al. The role of hepatic macrophages in liver metastasis. Cell Immunol. 2018;330:202–215.
   PubMed Web of Science ®Google Scholar
• Gangopadhyay A, Lazure DA, Thomas P. Adhesion of colorectal carcinoma cells to the endothelium is mediated by cytokines from CEA stimulated Kupffer cells. Clin Exp Metastasis. 1998 Nov;16(8):703–712.
   PubMed Web of Science ®Google Scholar
• Thomas P, Hayashi H, Zimmer R, et al. Regulation of cytokine production in carcinoembryonic antigen stimulated Kupffer cells by beta-2 adrenergic receptors: implications for hepatic metastasis. Cancer Lett. 2004 Jun 25;209(2):251–257.
   PubMed Web of Science ®Google Scholar
• Lee JH, Lee SW. The roles of carcinoembryonic antigen in liver metastasis and therapeutic approaches. Gastroenterol Res Pract. 2017;2017:1–11.
   Web of Science ®Google Scholar
• Paschos KA, Majeed AW, Bird NC. Role of Kupffer cells in the outgrowth of colorectal cancer liver metastases. Hepatol Res. 2010 Jan 1;40(1):83–94.
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Amano H, Ito Y, et al. Angiotensin II subtype 1a receptor signaling in resident hepatic macrophages induces liver metastasis formation. Cancer Sci. 2017 Sep;108(9):1757–1768.
   PubMed Web of Science ®Google Scholar
• Wohlfeil SA, Häfele V, Dietsch B, et al. Hepatic endothelial notch activation protects against liver metastasis by regulating endothelial-tumor cell adhesion independent of angiocrine signaling. Cancer Res. 2019 Feb 1;79(3):598–610.
   PubMed Web of Science ®Google Scholar
• Benedicto A, Herrero A, Romayor I, et al. Liver sinusoidal endothelial cell ICAM-1 mediated tumor/endothelial crosstalk drives the development of liver metastasis by initiating inflammatory and angiogenic responses. Sci Rep. 2019 Sep 11;9(1):13111–13122.
   PubMed Web of Science ®Google Scholar
• Liu W, Tang L, Zhang G, et al. Characterization of a novel C-type lectin-like gene, LSECtin: demonstration of carbohydrate binding and expression in sinusoidal endothelial cells of liver and lymph node. J Biol Chem. 2004 Apr 30;279(18):18748–18758.
   PubMed Web of Science ®Google Scholar
• Na H, Liu X, Li X, et al. Novel roles of DC-SIGNR in colon cancer cell adhesion, migration, invasion, and liver metastasis. J Hematol Oncol. 2017 Jan 21;10(1):28–45.
   PubMedGoogle Scholar
• Zuo Y, Ren S, Wang M, et al. Novel roles of liver sinusoidal endothelial cell lectin in colon carcinoma cell adhesion, migration and in-vivo metastasis to the liver. Gut. 2013 Aug;62(8):1169–1178.
   PubMed Web of Science ®Google Scholar
• Tang L, Yang J, Liu W, et al. Liver sinusoidal endothelial cell lectin, LSECtin, negatively regulates hepatic T-cell immune response. Gastroenterology. 2009 Oct;137(4):1498–1508.
   PubMed Web of Science ®Google Scholar
• Peinado H, Lavotshkin S, Lyden D. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol. 2011 Apr;21(2):139–146.
   PubMed Web of Science ®Google Scholar
• McAllister SS, Weinberg RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol. 2014 Aug;16(8):717–727.
   PubMed Web of Science ®Google Scholar
• Becker A, Thakur BK, Weiss JM, et al. Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell. 2016 Dec 12;30(6):836–848.
   PubMed Web of Science ®Google Scholar
• Hughes CE, Nibbs RJB. A guide to chemokines and their receptors. Febs J. 2018 Aug;285(16):2944–2971.
   PubMed Web of Science ®Google Scholar
• Bikfalvi A, Billottet C. The CC and CXC chemokines: major regulators of tumor progression and the tumor microenvironment. Am J Physiol Cell Physiol. 2020 Mar 1;318(3):C542–C554.
   PubMed Web of Science ®Google Scholar
• Keeley EC, Mehrad B, Strieter RM. CXC chemokines in cancer angiogenesis and metastases. Adv Cancer Res. 2010;106:91–111.
   PubMed Web of Science ®Google Scholar
• Itatani Y, Kawada K, Inamoto S, et al. The role of chemokines in promoting colorectal cancer invasion/metastasis. Int J Mol Sci. 2016 Apr 28;17(5):643–659.
   Web of Science ®Google Scholar
• Ichikawa M, Williams R, Wang L, et al. S100A8/A9 activate key genes and pathways in colon tumor progression. Mol Cancer Res. 2011 Feb;9(2):133–148.
   PubMed Web of Science ®Google Scholar
• Kitamura T, Kometani K, Hashida H, et al. SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion. Nat Genet. 2007 Apr;39(4):467–475.
   PubMed Web of Science ®Google Scholar
• Santoni M, Bracarda S, Nabissi M, et al. CXC and CC chemokines as angiogenic modulators in nonhaematological tumors. Biomed Res Int. 2014;2014:1–12.
   Web of Science ®Google Scholar
• Wang D, Wang H, Brown J, et al. CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med. 2006 Apr 17;203(4):941–951.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tan X, Luo J, et al. GNA13 promotes tumor growth and angiogenesis by upregulating CXC chemokines via the NF-κB signaling pathway in colorectal cancer cells. Cancer Med. 2018 Nov;7(11):5611–5620.
   PubMed Web of Science ®Google Scholar
• Chin AR, Wang SE. Cancer tills the premetastatic field: mechanistic basis and clinical implications. Clin Cancer Res off J Am Assoc Cancer Res. 2016 Aug 1;22(15):3725–3733.
   PubMed Web of Science ®Google Scholar
• Shojaei F, Wu X, Qu X, et al. G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models. Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6742–6747.
   PubMed Web of Science ®Google Scholar
• Grünwald B, Harant V, Schaten S, et al. Pancreatic premalignant lesions secrete tissue inhibitor of Metalloproteinases-1, which activates hepatic stellate cells via CD63 signaling to create a premetastatic niche in the liver. Gastroenterology. 2016 Nov;151(5):1011–1024.
   PubMed Web of Science ®Google Scholar
• Gordon-Weeks AN, Lim SY, Yuzhalin AE, et al. Neutrophils promote hepatic metastasis growth through fibroblast growth factor 2-dependent angiogenesis in mice. Hepatology. 2017 Jun;65(6):1920–1935.
   PubMed Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science (New York, NY). 2020 Feb 7;367(6478):6977–6991.
   Google Scholar
• Wu M, Wang G, Hu W, et al. Emerging roles and therapeutic value of exosomes in cancer metastasis. Mol Cancer. 2019 Mar 30;18(1):53–63.
   PubMedGoogle Scholar
• Costa-Silva B, Aiello NM, Ocean AJ, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol. 2015 Jun;17(6):816–826.
   PubMed Web of Science ®Google Scholar
• Liu Y, Gu Y, Han Y, et al. Tumor exosomal RNAs promote lung pre-metastatic niche formation by activating alveolar epithelial TLR3 to recruit neutrophils. Cancer Cell. 2016 Aug 8;30(2):243–256.
   PubMed Web of Science ®Google Scholar
• Peinado H, Alečković M, Lavotshkin S, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med. 2012 Jun;18(6):883–891.
   PubMed Web of Science ®Google Scholar
• Valenti R, Huber V, Filipazzi P, et al. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes. Cancer Res. 2006 Sep 15;66(18):9290–9298.
   PubMed Web of Science ®Google Scholar
• Chalmin F, Ladoire S, Mignot G, et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest. 2010 Feb;120(2):457–471.
   PubMed Web of Science ®Google Scholar
• Poggio M, Hu T, Pai CC, et al. Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory. Cell. 2019 Apr 4;177(2):414–427.
   PubMed Web of Science ®Google Scholar
• Zhuang G, Wu X, Jiang Z, et al. Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. Embo J. 2012 Aug 29;31(17):3513–3523.
   PubMed Web of Science ®Google Scholar
• Shang A, Wang X, Gu C, et al. Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1. Aging (Albany NY). 2020 May 3;12(9):8352–8371.
   PubMedGoogle Scholar
• Huang Z, Feng Y. Exosomes derived from hypoxic colorectal cancer cells promote angiogenesis through Wnt4-Induced β-Catenin signaling in endothelial cells. Oncol Res. 2017 May 24;25(5):651–661.
   PubMed Web of Science ®Google Scholar
• Baig MS, Roy A, Rajpoot S, et al. Tumor-derived exosomes in the regulation of macrophage polarization. Inflammation Res. 2020 May;69(5):435–451.
   PubMed Web of Science ®Google Scholar
• Shinohara H, Kuranaga Y, Kumazaki M, et al. Regulated polarization of tumor-associated macrophages by miR-145 via colorectal cancer-derived extracellular vesicles. J Immunol. 2017 Aug 15;199(4):1505–1515.
   PubMed Web of Science ®Google Scholar
• Wang D, Wang X, Si M, et al. Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages. Cancer Lett. 2020 Apr 1;474:36–52.
   PubMed Web of Science ®Google Scholar
• Wang X, Ding X, Nan L, et al. Investigation of the roles of exosomes in colorectal cancer liver metastasis. Oncol Rep. 2015 May;33(5):2445–2453.
   PubMed Web of Science ®Google Scholar
• Omoto T, Kim-Kaneyama JR, Lei XF, et al. The impact of stromal Hic-5 on the tumorigenesis of colorectal cancer through lysyl oxidase induction and stromal remodeling. Oncogene. 2018 Mar;37(9):1205–1219.
   PubMed Web of Science ®Google Scholar
• Cui X, Wang G, Shen W, et al. Lysyl oxidase-like 2 is highly expressed in colorectal cancer cells and promotes the development of colorectal cancer. Oncol Rep. 2018 Aug;40(2):932–942.
   PubMed Web of Science ®Google Scholar
• Baker AM, Bird D, Welti JC, et al. Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis. Cancer Res. 2013 Jan 15;73(2):583–594.
   PubMed Web of Science ®Google Scholar
• Erler JT, Bennewith KL, Cox TR, et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell. 2009 Jan 6;15(1):35–44.
   PubMed Web of Science ®Google Scholar
• Sceneay J, Chow MT, Chen A, et al. Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. Cancer Res. 2012 Aug 15;72(16):3906–3911.
   PubMed Web of Science ®Google Scholar
• Zoccoli A, Iuliani M, Pantano F, et al. Premetastatic niche: ready for new therapeutic interventions? Expert Opin Ther Targets. 2012 Apr;16(S2):S119–29.
   PubMedGoogle Scholar
• Peinado H, Zhang H, Matei IR, et al. Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer. 2017 May;17(5):302–317.
   PubMed Web of Science ®Google Scholar
• Lee JW, Stone ML, Porrett PM, et al. Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature. 2019 Mar;567(7747):249–252.
   PubMed Web of Science ®Google Scholar